360 related articles for article (PubMed ID: 15193059)
1. [Diagnostic usefulness of the Carlsson-Dent questionnaire in gastroesophageal reflux disease (GERD)].
Gómez-Escudero O; Remes-Troche JM; Ruíz JC; Peláez-Luna M; Schmulson MJ; Valdovinos Díaz MA
Rev Gastroenterol Mex; 2004; 69(1):16-23. PubMed ID: 15193059
[TBL] [Abstract][Full Text] [Related]
2. [Perception of symptoms with minimal reductions of esophageal pH in patients with erosive and non-erosive GERD].
Remes-Troche JM; Gómez-Escudero O; Ruíz JC; Schmulson MJ; Valdovinos Díaz MA
Rev Gastroenterol Mex; 2004; 69(1):30-6. PubMed ID: 15193061
[TBL] [Abstract][Full Text] [Related]
3. [Non-erosive gastroesophageal reflux disease. Incidence of clinical forms, characteristics of esophageal exposure to acid and symptomatic correlations].
Soto Pérez JC; Icaza ME; Vargas F; Valdovinos Díaz MA
Rev Gastroenterol Mex; 2003; 68(2):113-9. PubMed ID: 15127647
[TBL] [Abstract][Full Text] [Related]
4. Impact of measurement of esophageal acid exposure close to the gastroesophageal junction on diagnostic accuracy and event-symptom correlation: a prospective study using wireless dual pH monitoring.
Bansal A; Wani S; Rastogi A; Rastogi K; Goyal A; Hall S; Singh V; Higbee A; Sharma P
Am J Gastroenterol; 2009 Dec; 104(12):2918-25. PubMed ID: 19755975
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
[TBL] [Abstract][Full Text] [Related]
6. Impact of 24-h esophageal pH monitoring on the diagnosis of gastroesophageal reflux disease: defining the gold standard.
Madan K; Ahuja V; Gupta SD; Bal C; Kapoor A; Sharma MP
J Gastroenterol Hepatol; 2005 Jan; 20(1):30-7. PubMed ID: 15610443
[TBL] [Abstract][Full Text] [Related]
7. [Anxiety and depression related to the symptoms of gastroesophageal reflux disease].
Xu ZJ; Duan LP; Wang K; Xia ZW; Lin SR
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3210-5. PubMed ID: 16405842
[TBL] [Abstract][Full Text] [Related]
8. Stratification and symptom characteristics of non-erosive reflux disease based on acid and duodenogastroesophageal reflux.
Xiong LS; Chen MH; Lin JK; Hu PJ
J Gastroenterol Hepatol; 2008 Feb; 23(2):290-5. PubMed ID: 17924953
[TBL] [Abstract][Full Text] [Related]
9. Typical GERD symptoms and esophageal pH monitoring are not enough to diagnose pharyngeal reflux.
Oelschlager BK; Chang L; Pope CE; Pellegrini CA
J Surg Res; 2005 Sep; 128(1):55-60. PubMed ID: 16115493
[TBL] [Abstract][Full Text] [Related]
10. Belching: dyspepsia or gastroesophageal reflux disease?
Lin M; Triadafilopoulos G
Am J Gastroenterol; 2003 Oct; 98(10):2139-45. PubMed ID: 14572558
[TBL] [Abstract][Full Text] [Related]
11. [Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)].
Mönkemüller K; Neumann H; Fry LC; Kolfenbach S; Malfertheiner P
Z Gastroenterol; 2009 Apr; 47(4):351-6. PubMed ID: 19358061
[TBL] [Abstract][Full Text] [Related]
12. Can the combination of symptoms and endoscopy confirm the presence of gastroesophageal reflux disease?
Tefera L; Fein M; Ritter MP; Bremner CG; Crookes PF; Peters JH; Hagen JA; DeMeester TR
Am Surg; 1997 Oct; 63(10):933-6. PubMed ID: 9322676
[TBL] [Abstract][Full Text] [Related]
13. Comparison of esophageal acid exposure distribution along the esophagus among the different gastroesophageal reflux disease (GERD) groups.
Dickman R; Bautista JM; Wong WM; Bhatt R; Beeler JN; Malagon I; Risner-Adler S; Lam KF; Fass R
Am J Gastroenterol; 2006 Nov; 101(11):2463-9. PubMed ID: 17090277
[TBL] [Abstract][Full Text] [Related]
14. Value of heartburn for diagnosing gastroesophageal reflux disease in severely obese patients.
Ortiz V; Ponce M; Fernández A; Martínez B; Ponce JL; Garrigues V; Ponce J
Obesity (Silver Spring); 2006 Apr; 14(4):696-700. PubMed ID: 16741272
[TBL] [Abstract][Full Text] [Related]
15. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
[TBL] [Abstract][Full Text] [Related]
16. Omeprazole as a diagnostic tool in gastroesophageal reflux disease.
Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Festen HP; Jansen EH; Tuynman HA; Schrijver M; Dieleman LA; Meuwissen SG
Am J Gastroenterol; 1997 Nov; 92(11):1997-2000. PubMed ID: 9362179
[TBL] [Abstract][Full Text] [Related]
17. The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy.
Savarino E; Zentilin P; Tutuian R; Pohl D; Casa DD; Frazzoni M; Cestari R; Savarino V
Am J Gastroenterol; 2008 Nov; 103(11):2685-93. PubMed ID: 18775017
[TBL] [Abstract][Full Text] [Related]
18. The utility of intraluminal impedance in patients with gastroesophageal reflux disease-like symptoms but normal endoscopy and 24-hour pH testing.
Kline MM; Ewing M; Simpson N; Laine L
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):880-5; quiz 836. PubMed ID: 18424190
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic values of GerdQ, 24-h ambulatory oesophageal pH and impedance-pH monitoring in Barrett's esophagus, reflux esophagitis and non-erosive reflux disease].
Wang K; Duan LP; Ge Y; Xu ZJ; Xia ZW
Zhonghua Yi Xue Za Zhi; 2011 May; 91(18):1228-32. PubMed ID: 21756791
[TBL] [Abstract][Full Text] [Related]
20. [Successful esophageal pH monitoring with Bravo capsule in patients with gastroesophageal reflux disease].
Valdovinos Díaz MA; Remes Troche JM; Ruiz Aguilar JC; Schmulson MJ; Valdovinos-Andraca F
Rev Gastroenterol Mex; 2004; 69(2):62-8. PubMed ID: 15757153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
